Company / Return on Assets (ROA)
Larimar Therapeutics, Inc. Return on Assets (ROA) History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-64.4%
FY2019
5-year range
-70.4% / -7.4%
FY2015-FY2019
Trend
-35.6%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 6 years, ranging from -70.4% in FY2017 to -7.4% in FY2015.
Based on SEC 10-K filings.
-64.4% in FY2019 with a 5-year CAGR of -52.6%.
Improved from -70.4% to -64.4% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -36.7pp
- 5-Year Change
- -52.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, return on assets (roa) decreased 35.6% year-over-year.
- Peak return on assets (roa) was recorded in FY2015.
- Lowest return on assets (roa) in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | -64.4% | -35.6% |
| FY2018 | -47.5% | +32.5% |
| FY2017 | -70.4% | -154.1% |
| FY2016 | -27.7% | -273.5% |
| FY2015 | -7.4% | +37.2% |
| FY2014 | -11.8% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026